321 related articles for article (PubMed ID: 29496619)
1. Association between antiretroviral therapy and antitubercular drug resistance in TB treatment outcome among Kazakh TB/HIV co-infected patients.
Mishkin K; Alaei K; Alikeyeva E; Paynter C; Aringazina A; Alaei A
J Glob Antimicrob Resist; 2018 Sep; 14():104-108. PubMed ID: 29496619
[TBL] [Abstract][Full Text] [Related]
2. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
3. Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study.
Sinshaw Y; Alemu S; Fekadu A; Gizachew M
BMC Infect Dis; 2017 Feb; 17(1):132. PubMed ID: 28178936
[TBL] [Abstract][Full Text] [Related]
4. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study.
Zhang L; Xing W; Zhou J; Zhang R; Cheng Y; Li J; Wang G; Liu S; Li Y
BMC Infect Dis; 2020 Aug; 20(1):576. PubMed ID: 32758169
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis treatment outcome and its associated factors among people living with HIV and AIDS in Fako Division of Cameroon.
Tanue EA; Nsagha DS; Njamen TN; Assob NJC
PLoS One; 2019; 14(7):e0218800. PubMed ID: 31361755
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of tuberculosis prophylaxis in patients with HIV/AIDS - retrospective analysis of data from Almaty, Kazakhstan, 2010-2015.
Juszkiewicz K; Jarosz MJ; Włoszczak-Szubzda A; Głowacka M
Ann Agric Environ Med; 2020 Dec; 27(4):695-701. PubMed ID: 33356080
[TBL] [Abstract][Full Text] [Related]
8. Substantially Higher and Earlier Occurrence of Anti-Tuberculosis Drug-Related Adverse Reactions in HIV Coinfected Tuberculosis Patients: A Matched-Cohort Study.
Matono T; Nishijima T; Teruya K; Morino E; Takasaki J; Gatanaga H; Kikuchi Y; Kaku M; Oka S
AIDS Patient Care STDS; 2017 Nov; 31(11):455-462. PubMed ID: 29087745
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
Bastard M; Sanchez-Padilla E; du Cros P; Khamraev AK; Parpieva N; Tillyashaykov M; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Perez SF; Telnov A; Hewison C; Varaine F; Bonnet M
PLoS One; 2018; 13(3):e0193491. PubMed ID: 29518098
[TBL] [Abstract][Full Text] [Related]
10. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
Carlucci JG; Blevins Peratikos M; Kipp AM; Lindegren ML; Du QT; Renner L; Reubenson G; Ssali J; Yotebieng M; Mandalakas AM; Davies MA; Ballif M; Fenner L; Pettit AC;
J Acquir Immune Defic Syndr; 2017 Jun; 75(2):156-163. PubMed ID: 28234689
[TBL] [Abstract][Full Text] [Related]
12. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.
Walls G; Bulifon S; Breysse S; Daneth T; Bonnet M; Hurtado N; Molfino L
Glob Health Action; 2015; 8():25964. PubMed ID: 25623609
[TBL] [Abstract][Full Text] [Related]
13. Risks for tuberculosis in Kazakhstan: implications for prevention.
Davis A; Terlikbayeva A; Aifah A; Hermosilla S; Zhumadilov Z; Berikova E; Rakhimova S; Primbetova S; Darisheva M; Schluger N; El-Bassel N
Int J Tuberc Lung Dis; 2017 Jan; 21(1):86-92. PubMed ID: 28157470
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah T; Ncayiyana J; Padanilam X; Nyasulu PS
BMC Infect Dis; 2015 Oct; 15():478. PubMed ID: 26511616
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis and HIV Coinfection.
Bruchfeld J; Correia-Neves M; Källenius G
Cold Spring Harb Perspect Med; 2015 Feb; 5(7):a017871. PubMed ID: 25722472
[TBL] [Abstract][Full Text] [Related]
16. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes.
Monge S; Diez M; Pulido F; Iribarren JA; Campins AA; Arazo P; Montero M; Miro JM; Moreno S; Del Amo J;
Int J Tuberc Lung Dis; 2014 Jun; 18(6):700-8. PubMed ID: 24903942
[TBL] [Abstract][Full Text] [Related]
18. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
Kasozi S; Kirirabwa NS; Kimuli D; Luwaga H; Kizito E; Turyahabwe S; Lukoye D; Byaruhanga R; Chen L; Suarez P
PLoS One; 2020; 15(12):e0244451. PubMed ID: 33373997
[TBL] [Abstract][Full Text] [Related]
19. The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
Ezati N; Lukoye D; Wampande EM; Musisi K; Kasule GW; Cobelens FG; Kateete DP; Joloba ML
BMC Infect Dis; 2014 Dec; 14():703. PubMed ID: 25523472
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis, drug use and HIV infection in Central Asia: an urgent need for attention.
Schluger NW; El-Bassel N; Hermosilla S; Terlikbayeva A; Darisheva M; Aifah A; Galea S
Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S32-6. PubMed ID: 23928052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
